Dental Core Trainee OMFS/ Clinical Lecturer in Oral Medicine at Sheffield Teaching Hospital, United Kingdom
Dr. Esra B. Amoura is an accomplished academic and clinical professional in the field of oral and maxillofacial medicine, combining her expertise in dentistry, diagnostic pathology, and oncology research. Currently serving as a Clinical Lecturer in Oral Medicine at the University of Manchester, she has made significant contributions to the understanding of head and neck cancers, specifically mucoepidermoid carcinoma. Her career reflects a unique integration of clinical care, research excellence, and academic mentorship.
Profile
ORCID
Education
Dr. Amoura holds a Ph.D. in Oral Pathology from the University of Sheffield (2021), where her research explored the expression and function of the CRTC1-MAML2 fusion protein in mucoepidermoid carcinoma. She completed a Master of Medical Science in Diagnostic Oral Pathology in 2014 and earned her Bachelor of Dental Surgery with distinction from the University of Tripoli in 2006. Her academic journey is marked by excellence and dedication to advancing oral cancer research.
Experience
With a progressive trajectory from a demonstrator in Libya to her current lecturer position in the UK, Dr. Amoura has accumulated extensive clinical and academic experience. She served as a Research Associate at the University of Sheffield and held several Dental Core Training roles across Oral Medicine and Maxillofacial Surgery units in Sheffield. Her teaching portfolio spans both undergraduate and postgraduate levels, covering clinical teaching, practical demonstrations, and module lectures across various dental disciplines.
Research Interest
Dr. Amoura’s research focuses on molecular oncology in head and neck cancers, particularly mucoepidermoid carcinoma. Her investigations emphasize the molecular mechanisms involving the CRTC1-MAML2 translocation and its role in tumor biology. She is also interested in clinical case presentations related to oral pathology, oral medicine, and reconstructive oral surgery, often linking translational research with patient care.
Publication
Dr. Amoura’s research output includes impactful publications that reflect her commitment to advancing scientific knowledge:
-
2021 – “In Situ Detection of the CRTC1-MAML2 Translocation Expression in Mucoepidermoid Carcinoma”, published abstract (Amoura et al.).
-
2021 – “An Investigation into the Expression and the Role of the CRTC1-MAML2 Fusion Protein in MEC”, Ph.D. thesis, University of Sheffield.
-
2020 – “TrkB-targeted therapy for Mucoepidermoid Carcinoma”, co-authored in collaboration with international researchers (Wagner et al.).
-
2023 – “Submandibular Foregut Duplication Cyst: A case report”, BAOMS Annual Scientific Meeting, London.
-
2023 – “Fibula Free Flap Vascular Pedicle Calcification”, presented at BAOMS Annual Scientific Meeting, London.
These publications underscore her international collaborative efforts and contributions to oral cancer biology and clinical pathology.